Muri and Carreira
JOCArticle
solution was stirred for 3 h at 0 °C and then quenched with H2O
(2 mL) and solid NaHCO3 (2.5 g) with care. The biphasic
mixture was extracted with EtOAc (5 ꢀ 5 mL). The combined
organic solutions were washed with 1 N HCl (50 mL) and brine
(5 mL), dried over anhydrous Na2SO4, and concentrated under
reduced pressure. Purification by chromatography on silica gel
(hexane/EtOAc 1:1 to 1:3) afforded triol 44 (220 mg, 80% yield)
as a colorless foam. Rf = 0.18 (1:1 hexane/EtOAc). [R]D24.5
(c 2.650, CHCl3) = -14°. 1H NMR (300 MHz, CDCl3) δ:
7.53-7.49 (m, 2H), 7.39-7.32 (m, 3H), 5.50 (s, 1H), 4.34 (d, 1H,
J = 8.7 Hz), 3.70 (d, 1H, J = 1.0 Hz), 3.68-3.53 (m, 4H),
3.32-3.18 (m, 2H), 2.92-2.86 (m, 1H), 2.43-2.22 (m, 3H),
2.06-2.00 (m, 1H), 1.90-1.83 (m, 1H), 1.74-1.67 (m, 1H), 1.62
(dd, 1H, J = 14.5, 4.9 Hz), 1.45-1.40 (m, 1H), 1.36 (d, 3H, J =
7.6 Hz), 1.34 (s, 3H), 1.24 (d, 3H, J = 8.9 Hz), 1.23 (s, 3H), 1.08
(t, 3H, J = 7.1 Hz), 1.09 (d, 3H, J = 6.5 Hz), 1.02 (d, 3H, J = 6.7
Hz), 0.85 (t, 9H, J = 7.8 Hz), 0.51 (q, 6H, J = 7.8 Hz). 13C NMR
(75 MHz, CDCl3) δ: 170.1, 138.8, 128.5, 127.9, 126.3, 102.5,
86.8, 85.7, 84.3, 81.4, 78.0, 73.9, 63.3, 45.3, 42.6, 36.0, 31.2, 27.0,
26.0, 25.1, 22.5, 20.5, 14.1, 13.1, 11.7, 8.1, 7.3, 6.7. IR (thin film)
3414, 2957, 2875, 1457, 1406, 1376, 1350, 1311, 1238, 1215, 1132,
1105, 1050, 1029, 1013, 974, 743, 698 (cm-1). HRMS-MALDI
(m/z) calcd for [C34H59NO7SiNa]þ, 644.3953; found, 644.3945.
3,5-O-Benzylidene-2,4,7-trideoxy-6-C-((2R)-2-{(4S,5R)-5-[(2R)-
2-hydroxy-1,1-dimethylbutyl]-4-methyl-4,5-dihydroisoxazol-3-yl}-
propyl)-2,4-dimethyl-3,5-O-(1-methylethylidene)-6-O-(triethyl-
silyl)-L-glycero-L-ido-heptonic Acid (45).
169.3, 138.5, 128.7, 128.0, 126.4, 102.6, 86.7, 85.8, 82.0, 81.8,
78.2, 74.2, 45.2, 42.3, 41.4, 32.1, 26.9, 26.1, 24.9, 22.5, 20.7,
14.8, 12.9, 11.7, 8.1, 7.3, 6.7. IR (thin film) 3450, 2957, 2876,
1722, 1457, 1407, 1379, 1348, 1312, 1274, 1239, 1215, 1129, 1105,
1065, 1028, 1007, 976, 938, 912, 884, 757, 698, 668 (cm-1).
HRMS-MALDI (m/z) calcd for [C34H57NO8SiNa]þ, 658.3746;
found, 658.3739.
(1R,2R,4R,8R,9R,10R,13R,14S,18S,19S)-10-Ethyl-9-hydroxy-
2,4,9,13,18,19-hexamethyl-16-phenyl-2-[(triethylsilyl)oxy]-7,11,15,
17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one (46).
To a solution of acid 45 (136 mg, 0.214 mmol, 1.00 equiv) in
THF (4.0 mL) were added NEt3 (179 μL, 1.28 mmol, 6.00 equiv)
and 2,4,6-trichlorobenzoylchloride (167 μL, 1.07 mmol, 5.00
equiv) at 0 °C. The solution turned cloudy and was stirred for 30
min. The colorless suspension was allowed to warm to rt, and
toluene (12 mL) was added. This cloudy reaction mixture was
added to a 50 °C solution of DMAP (261 mg, 2.14 mmol, 10.0
equiv) in toluene (24.0 mL) via syringe pump over 3 h. After
addition, the stirring was maintained for another 45 min at 50 °C
before the colorless suspension was filtered over a plug of silica
gel (eluent hexane/EtOAc 1:1). The filtrate was concentrated
under reduced pressure. Purification by chromatography on
silica gel (hexane/EtOAc 10:1 to 6:1 to 3:1) provided macro-
lactone 46 (103 mg, 78% yield) as a colorless foam and as a mix-
ture of two atropisomers (7:2). Rf = 0.28 and 0.37* (3:1 hexane/
EtOAc, *denotes minor isomer). [R]2D2.6 (c 0.730, CHCl3) =
-49°. 1H NMR (300 MHz, CDCl3, *denotes minor isomer) δ:
7.53-7.46 (m, 2H), 7.39-7.30 (m, 3H), 5.58 (s, 1H), 5.43* (s,
1H), 5.03 (dd, 1H, J = 10.6, 2.5 Hz), 4.83* (dd, 1H, J = 9.0, 1.9
Hz), 4.49* (d, 1H, J = 9.5 Hz), 4.15 (d, 1H, J = 6.3 Hz), 4.10 (d,
1H, J = 1.4 Hz), 3.95 (dd, 1H, J = 8.2, 1.1 Hz), 3.90* (dd, 1H,
J = 6.3, 1.4 Hz), 3.62* (d, 1H, J = 1.3 Hz), 3.60-3.50 (m, 1H),
2.91-2.82 (m, 1H), 2.79-2.69 (m, 1H), 2.17-2.05* (m, 1H),
2.04 (s, 1H), 1.93-1.80 (m, 1H), 1.81 (dd, 1H, J = 15.1, 7.9 Hz),
1.72-1.64* (ddd, 1H, J = 14.4, 7.5, 2.1 Hz), 1.65-1.45 (m, 3H),
1.41* (dd, 1H, J = 15.0, 1.6 Hz), 1.28 (s, 3H), 1.27 (d, 3H, J =
6.9 Hz), 1.22 (d, 3H, J = 7.0 Hz), 1.18 (s, 3H), 1.17 (d, 3H, J =
7.0 Hz), 1.01 (d, 3H, J = 6.7 Hz), 0.96 (t, 3H, J = 7.4 Hz), 0.85 (t,
9H, J = 8.0 Hz), 0.59-0.39 (m, 6H). 13C NMR (75 MHz,
CDCl3, *denotes minor isomer) δ: 175.4, 172.3, 165.3*, 138.7,
128.5, 127.8, 126.4, 102.7*, 102.5, 86.9*, 85.4, 84.9*, 84.3, 83.3*,
82.3*, 81.8, 79.1, 78.7*, 78.4, 78.2*, 72.8, 47.4, 45.4*, 43.4*, 42.0,
41.0, 34.4*, 34.2, 27.8, 27.0, 26.4*, 26.1*, 25.6*, 23.0*, 22.6*,
21.4, 21.3, 17.5, 14.0, 12.6*, 11.2*, 11.0, 10.3*, 7.8, 7.3, 6.8. IR
(thin film) 3438, 2954, 2876, 1741, 1456, 1379, 1349, 1236,
1159, 1129, 1080, 1007, 972, 908, 741, 699 (cm-1). HRMS-
MALDI (m/z) calcd for [C34H55NO7SiNa]þ, 640.3640; found,
640.3634.
To a biphasic solution of triol 44 (220 mg, 0.35 mmol, 1.0
equiv), TEMPO (8.3 mg, 0.053 mmol, 0.15 equiv), and KBr
(4.1 mg, 0.035 mmol, 0.10 equiv) in CH2Cl2 (4.0 mL) and pH 8.6
buffer (4.0 mL) was slowly added NaOCl (0.5 M in H2O, 2.8 mL,
1.4 mmol, 4.0 equiv) at 0 °C. After stirring for 30 min at 0 °C, the
two layers were separated, and the aqueous layer was extracted
with CH2Cl2 (3 ꢀ 5 mL). The organic solution was washed with
brine (10 mL), dried over Na2SO4, and concentrated in vacuo.
The crude aldehyde was used without further purification. At
0 °C, a premixed solution of 2-methyl-2-butene (0.188 mL, 1.77
mmol, 5.00 equiv) and NaClO2 (96.3 mg, 1.06 mmol, 3.00 equiv)
in t-BuOH (9.0 mL) and pH 3.8 buffer (1.8 mL) was added to the
crude aldehyde (220 mg, 0.355 mmol, 1.00 equiv). After 30 min of
stirring at 0 °C, more pH 3.8 buffer (3.0 mL) was added, and the
solution was extracted with EtOAc (6 ꢀ 5 mL). The organic
solution was washed with brine (5 mL), dried over anhydrous
Na2SO4, and concentrated under reduced pressure. Purifiaction
by chromatography on silica gel (hexane/EtOAc 2:1 to 2:1 þ 1%
HOAc) provided seco-acid 45 (187 mg, 83% yield over two steps)
as a clear, colorless oil. Rf = 0.38 (1:1 hexane/EtOAc þ 1%
HOAc). [R]2D5.4 (c 2.650, CHCl3) = -32°. 1H NMR (300 MHz,
CDCl3) δ: 7.51-7.46 (m, 2H), 7.40-7.32 (m, 3H), 5.51 (s, 1H),
4.40 (d, 1H, J = 9.1 Hz), 3.75 (s, 1H), 3.73 (dd, 1H, J = 10.0, 0.8
Hz), 3.39 (d, 1H, J = 9.5 Hz), 3.29-3.24 (m, 1H), 2.81-2.74 (m,
2H), 2.45 (dd, 1H, J = 14.7, 3.4 Hz), 1.96-1.91 (m, 1H),
1.74-1.68 (m, 1H), 1.55 (dd, 1H, J = 14.6, 5.0 Hz), 1.48-1.42
(m, 1H), 1.37 (d, 3H, J = 7.4 Hz), 1.33 (s, 3H), 1.27 (d, 3H,
J = 6.7 Hz), 1.24 (s, 3H), 1.23 (d, 3H, J = 5.5 Hz), 1.09 (t, 3H,
J = 6.1 Hz), 1.08 (d, 3H, J = 6.5 Hz), 0.85 (t, 9H, J = 8.0 Hz),
0.50 (q, 6H, J = 8.0 Hz). 13C NMR (75 MHz, CDCl3) δ: 176.6,
(1R,2R,4R,8R,9R,10R,13R,14S,16R,18S,19S)-10-Ethyl-2,9-
dihydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-7,11,15,17-tet-
raoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one.
8710 J. Org. Chem. Vol. 74, No. 22, 2009